ARCHIVES

Avon, four companies Fund NABCO Patient Information Services

This article is from The Cancer Letter archive.

Vol. 20 No. 04 | January 28, 1994

Download PDF Visit The Full Archive

Related Articles

Soviet Exchanges Rise And Fall With Politics

August 23, 1991

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Conference asks NCAB To Develop Guidelines For Clinical Alerts; Must Be Investigator-Initiated

February 9, 1990

DCPC Board Oks Program To Encourage Produce Consumption

October 25, 1991

Funding Opportunities

September 20, 2002

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980